04791cam a2200853 i 4500 1266258710 OCoLC 20220525103634.0 220302s2022 nyuaf b 000 0 eng 2022001763 9780063210790 0063210797 (OCoLC)1266258710 (OCoLC)1252411451 (OCoLC)1273586219 (OCoLC)1286848313 (OCoLC)1291404130 (OCoLC)1296034824 (OCoLC)1301513438 Harpercollins, 53 Glenmaura National Blvd Ste 300, Moosaic, PA, USA, 18507-2132 SAN 200-2086 AJM pcc Bourla, Albert, author. 11162 Moonshot : inside Pfizer's nine-month race to make the impossible possible / Dr. Albert Bourla. Inside Pfizer's nine-month race to make the impossible possible Inside Pfizer's 9-month race to make the impossible possible First edition. New York, NY : Harper Business, an imprint of HarperCollinsPublishers, [2022] xix, 216 pages, 8 unnumbered pages of plates : illustrations (some color) ; 24 cm text txt rdacontent unmediated n rdamedia volume nc rdacarrier Includes bibliographical references (pages [197]-214). Preface: Luck never comes to the unprepared -- Business NOT as usual -- What is obvious is not always right -- Thinking big makes the impossible possible -- Lightspeed -- The ultimate joy -- Past, present, future -- Manufacturing, the second miracle -- Equity : easier said than done -- Navigating a political minefield -- A beacon of hope -- The science of trust -- A pro-patient, pro-innovation agenda -- Epilogue -- Acknowledgments -- Appendix: Albert Bourla's "we stand with science" open letter to colleagues. "The exclusive, first-hand, behind-the-scenes story of how Pfizer raced to create the first Covid-19 vaccine, told by Pfizer's CEO Dr. Albert Bourla"-- Provided by publisher. "A riveting, fast-paced, inside look at one of the most incredible private sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr. Albert Bourla, made "the impossible possible"--creating, testing, and manufacturing a safe and effective Covid-19 vaccine that previously would have taken years to develop." -- inside front book jacket flap. Bourla, Albert. 11162 Pfizer Inc. 11163 Pfizer Inc. fast (OCoLC)fst00532911 11163 fast (OCoLC)fst02024716 Drug development History. 11164 COVID-19 (Disease) Vaccination. 11165 Viral vaccines Biotechnology. 11166 Viral vaccines. 11167 Vaccines industry. 11168 Immunology. 11192 Biotechnology. 11193 COVID-19 (Disease) Prevention. 11194 COVID-19 Pandemic, 2020- 11195 COVID-19 vaccines History. 11196 mRNA vaccines History. 11197 Viral Vaccines 11167 Allergy and Immunology 11198 Biotechnology 11193 Médicaments Développement Histoire. 11199 COVID-19 Vaccination. 11200 Vaccins antiviraux Biotechnologie. 11201 Vaccins antiviraux. 11202 Vaccins Industrie. 11203 Immunologie. 11204 Biotechnologie. 11183 Pandémie de COVID-19, 2020- 11184 bioengineering. aat 11185 BUSINESS & ECONOMICS / Industries / Pharmaceutical & Biotechnology. bisacsh 11186 MEDICAL / Immunology. bisacsh 11187 BUSINESS & ECONOMICS / Research & Development. bisacsh 11188 Biotechnology. fast (OCoLC)fst00832729 11193 COVID-19 (Disease) Prevention. fast (OCoLC)fst02021842 11194 COVID-19 (Disease) Vaccination. fast (OCoLC)fst02021881 11165 Drug development. fast (OCoLC)fst00898670 11189 Immunology. fast (OCoLC)fst00968006 11192 Vaccines industry. fast (OCoLC)fst01163593 11168 Viral vaccines. fast (OCoLC)fst01167621 11167 Viral vaccines Research. fast (OCoLC)fst01167622 11190 COVID-19 (Disease) sears 11191 History. fast (OCoLC)fst01411628 49 Online version: Bourla, Dr. Albert. Moonshot New York : Harper Business, 2022 9780063210820 (DLC) 2022001764 .b173089355 ddc BOOK 28254 28254 ddc 0 0 ABELJ ABELJ NF 2022-05-25 1 614.4 BOUR 63675 2022-08-09 2022-07-29 2022-05-25 BOOK 1